The COVID-19 pandemic led to wide-scale global disruption of cancer care across a broad range
of cancers. Sixty-nine studies from 23 countries report changes in the patterns of screenings,
diagnoses, waiting lists and treatments for cancer related to restrictions during the COVID-19
pandemic in 2020. Fourteen studies report an increase in later-stage cancer presentations.
Future restrictions should consider the disruptions to cancer care pathways and plan to prevent
the unnecessary harms.
Appendices
Appendix 1. Review of the Impact of COVID-19 First Wave Restrictions on Cancer Care